REGENERAR Improving the Effectiveness and Safety of Epigenetic Editing in Brain Regeneration
- Coordinator
- Universidade De Coimbra, Portugal
- Runs
- 1 March 2024 to 29 February 2028
- Status
- Running
- EU funding
- €2.9m
- Total cost
- €2.9m
- Partners
- 6 organisations in 3 countries
- Type
- European Innovation Council
- Grant agreement
- 101129812
What the project is doing
In the project's own words, from its summary on CORDIS.
The central nervous system has a limited capacity for self-repair. Therefore, technologies to replace lost neurons after an injury, including stroke or neurodegenerative diseases, are of great need. The project REGENERAR aims to develop a non-viral delivery formulation up to TRL4 for the delivery of an epigenetic reprogramming formulation to reprogram glial cells into neurons. The in vitro safety and targeting of the formulation will be tested against glial cells and organotypic cortical slice cultures.
Several routes of administrations will be tested to enhance the accumulation of the formulation in the brain. In addition, the in vivo safety, elimination, targeting and epigenetic reprogramming will be evaluated. In addition, toxicological studies will be performed in GLP conditions to evaluate both in vivo systemic and local (brain) effects of the formulation. The development of the non-viral formulation will take in account the contributes of key stakeholders in the area of gene editing, health institutions, patient associations, among others.
A roadmap will be developed for upscaling innovation to higher TRL´s upon the end of the action.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universidade De Coimbra | Coimbra | Portugal | Coordinator |
| Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eV | Munchen | Germany | Participant |
| Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt GmbH | Neuherberg | Germany | Participant |
| Hovione Farmaciencia SA | Loures | Portugal | Participant |
| Sociedade Portuguesa De Inovacao Consultadoria Empresarial E Fomento Da Inovacao SA | Porto | Portugal | Participant |
| Single Technologies AB | Stockholm | Sweden | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI